STOCKS TELEGRAPH

Tag: ADMP

  • Early Morning Vibes: 4 Hot Stocks to Buy Before Weekend

    Early Morning Vibes: 4 Hot Stocks to Buy Before Weekend

    On January 21, American stock exchanges traded in a narrow range. The S&P 500 index rose by a symbolic 0.03%, to 3853 points, the NASDAQ added 0.55%, the Dow Jones lost 0.04%. The news background remained calm. Macro statistics were mostly better than expected. Growth stocks outperformed value stocks, reflecting the outperforming tech sector, climbing 1.32%.

    Company news

    According to media reports, Apple (AAPL: + 3.7%) is developing a gadget for interacting with virtual reality. The release is scheduled for 2022.

    United Airlines (UAL: -5.7%) quarterly results were in line with expectations, but the outlook for the next quarter disappointed investors.

    Oil and gas infrastructure company Kinder Morgan (KMI: -2%) performed well, but analysts are awaiting additional information, including forecasts, to be disclosed at an investor day scheduled for January 27.

    President Joseph Biden signed executive orders that set the framework for a new strategy to combat the epidemic. In particular, it is planned to deploy numerous vaccination sites and attract more health workers to it. One of the main barriers to revitalizing the vaccination campaign is insufficient government funding. To address this problem, the $ 1.9 trillion stimulus package presented by Biden included at least $ 160 billion in spending. Republicans criticized certain points of the proposed program. which also accounts for the peak reporting season. In this regard, volatility in the short term will be increased.

    Economic news

    Markit’s preliminary PMIs for January are worth checking out this Friday. In the manufacturing sector, according to the forecast, the indicator will drop from 57.1 to 56.5. In the service sector, a more significant decline is expected – from 54.8 to 53.6. The projected slowdown in business growth coincides with a short-term deterioration in the labor market. Overall, the pace of business recovery after the crisis remains satisfactory.

    Sentiment Index

    The Freedom Finance Sentiment Index climbed to 63 out of 100. The indicator reflects market participants’ hope for a global economic recovery in 2021. Concerns about the negative impact of the coronavirus pandemic are starting to wane thanks to the prospect of mass vaccinations.

    Technical picture

    Technically, the S&P 500 is showing an upward bias in the medium term. The relative strength of buyers prevails, but the upper border of the equidistant channel at 3860 points is a serious resistance. In this regard, short-term consolidation is quite possible.

    Today Top Movers

    ‎Adamis Pharma (ADMP) gained over 76.38% at $2.24 in pre-market ‎trading on Friday following an announcement from the firm that its SYMJEPI® (epinephrine) Injection products are now available to members of the Walgreens Prescription Savings Club program, for a discounted price of $99.99 for a two-pack‎‎.‎ ‎‎

    ‎Sierra Wireless Inc. (SWIR) grew over 7.61% at $19.80 in pre-market trading ‎today after the company received a bullish initiation from Wall Street. B. Riley Securities kicked off coverage of Sierra Wireless with a buy rating alongside a price target of $23.50”.‎‎‎ ‎‎

    ‎Zynga Inc (ZNGA) stock moved up 1.45 percent to $10.50 in the pre-market ‎trading. The electronic gaming & multimedia company is making headlines on Thursday as multiple news sources and traders circulate a TMT Finance report that Tencent (TCEHY) is considering finance for a large acquisition.‎‎‎ ‎‎

    ‎GameStop Corp (GME) is up more than 4.95% at $45.16 in pre-market ‎hours ‎Friday after news of the joining of Chewy founder and activist investor Ryan Cohen and two of his associates to GameStop’s board of directors. ‎‎

    Top Upgrades & Downgrades

    Keefe Bruyette turned bullish on Northern Trust Corporation (NTRS), upgrading the stock to “Outperform” and assigning a $120 price target, representing a potential upside of 27.36% from Thursday’s close. 

    Quidel Corporation (QDEL) has won the favor of Raymond James’s equity research team. The firm upgraded the shares from Market Perform to Outperform and moved their price target to $250.0, suggesting 14.42% additional upside for the stock.

    PacWest Bancorp (PACW) received an upgrade from analysts at Keefe Bruyette, who also set their one-year price target on the stock to $40. They changed their rating on PACW to Outperform from Market Perform in a recently issued research note.

    Earlier Friday Stifel reduced its rating on CSX Corporation (CSX) stock to Hold from Buy and assigned the price target to $92. With shares trading at around $91.61, the Wall Street firm thinks CSX Corporation’s stock could add than 0.42%.

    Jefferies analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Regis Corporation (RGS) has been changed to Hold from Buy and the new price target is set at $10.

    Analysts at BMO Capital downgraded Sage Therapeutics Inc. (SAGE)’s stock to Market Perform from Outperform Friday.

    Latest Insider Activity

    BlackBerry Limited (BB) EVP, Ent. Products & VAS HO BILLY announced the sale of shares taking place on Jan 20 at $12.95 for some 20,000 shares. The total came to more than $0.26 million.

    General Motors Company (GM) Executive Vice President & CIO MOTT RANDALL D sold on Jan 19 a total of 89,427 shares at $53.69 on average. The insider’s sale generated proceeds of almost $1.34 million.

    Petco Health and Wellness Company Inc. (WOOF) Chief Inf. & Admin. Officer Zavada John declared the purchase of shares taking place on Jan 19 at $18.00 for some 1,500 shares. The transaction amount was around $27000.

    Barnwell Industries Inc. (BRN) 10% Owner SHERWOOD NED L bought on Jan 20 a total 1,236,818 shares at $1.85 on average. The purchase cost the insider an estimated $34,969.

    Important Earnings

    Top US earnings releases scheduled for today include Schlumberger Limited (NYSE: SLB). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.17 per share from revenues of $5.25B in the three-month period.

    Analysts expect Huntington Bancshares Incorporated (NASDAQ: HBAN) to report a net income (adjusted) of $0.29 per share when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $1.25B.

    Regions Financial Corporation (RF), due to announce earnings after the market closes today, is expected to report earnings of $0.42 per share from revenues of $1.56B recently concluded three-month period.

  • Adamis Pharmaceuticals Corp (ADMP) shares slide 14% as traders take profits

    Adamis Pharmaceuticals Corp (ADMP) shares slide 14% as traders take profits

    Adamis Pharmaceuticals Corp (NASDAQ: ADMP) ‎ shares were down 14% in early trading Thursday. On Wednesday, shares jumped 78% to 1.43, likely on the FDA news. The biopharmaceutical firm announced a request to the FDA for the investigational use of its COVID-19 treatment drug Tempol.

    The meeting that followed the request tendered by Adamis Pharmaceuticals gave FDA-specific guidelines regarding the drug’s chemistry, manufacturing, and clinical aspects.

    Currently, the pharmaceutical firm plans to seek government and private arbitration for the funding to study the treatment and a preventive measure of COVID-19

    Its drug Tempol showed anti-inflammatory, anticoagulant, and anti-oxidant activity in patients. The cells are affected by inflammatory cytokines and reactive oxygen species that are because of Acute Respiratory Distress Syndrome, which is the main cause of lung capacity been degraded. Tempol used shows a decrease in cytokines and with its dosage shows signs of a decrease in the effect of reactive oxygen species. The drug also shows evidence of decrease platelet agitation, a problem that was observed and found in COVID-19 patients.

    Many experts claim the drug plays a pivotal role not only in combatting COVID-19 but actually will be possible in decreasing hospitalization. These claims will help cut healthcare costs to a substantial amount. With new mutations popping up all over the world, a new form of treatment and therapies should be reviewed.

    The company is famous for its epinephrine injection, which is useful to treat acute allergic reactions such as anaphylaxis. Its injection is FDA-approved for emergency use. The company also makes sterile drugs for humans and animals.

  • 15 Top Performing Stocks In Healthcare Industry

    15 Top Performing Stocks In Healthcare Industry

    The health care industry is considered to be the opportunity-rich industry. The demand in this industry is continuously increasing. Emerging technologies also play a very important role in the health care industry. Complex health and technology ecosystems and increasing consumer expectations are the major challenges which the health care industry is facing. Customers’ main priority is affordable and efficient drugs.

    If we look at the Drug manufacturers and specialty generic industry, this industry has seen a huge transformation over the last two decades. This industry is always striving to change fast enough to keep up with regulatory and patients needs. Currently, the healthcare industry has faced the major challenge of the COVID-19 pandemic. It is important to focus on what is happening in the market to increase industry growth.

    Here are the 15 leading companies in the Drug Manufacturers and specialty and generic industry:

    Zomedica Pharmaceuticals Corp. (AMEX: ZOM)

    Zomedica Pharmaceuticals Corp. (AMEX: ZOM) shares were trading up 42.86% at $0.10 at the time of writing on Monday. Zomedica Pharmaceuticals Corp. (AMEX: ZOM) share price went from a low point around $0.07 to briefly over $0.50 in past 52 weeks, though shares have since pulled back to $0.10. ZOM market cap has remained high, hitting $79.71M at the time of writing.

    Zomedica Pharmaceuticals Corp. has earlier revealed its proxy solicitor, Alliance Advisors, mailed the letter to selected shareholders in advance of its Annual and Special Virtual-Only Meeting of Shareholders. The virtual meeting is scheduled to hold on September 25, 2020.

    AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX)

    AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) last closed at $1.81, in a 52-week range of $0.70 to $2.68. AcelRx Pharmaceuticals Inc. (ACRX) announced today that the U.S. Army has granted AcelRx with an initial contract of up to approximately $3.6 million for the purchase of DSUVIA to support a study to aid the development of clinical practice guidelines. This company’s market capitalization has remained high, hitting $142.61 million at the time of writing.

    PPD Inc. (NASDAQ: PPD)

    PPD Inc. (NASDAQ: PPD) stock soar by 0.92% to $34.16. The most recent rating by KeyBanc Capital Markets, on June 04, 2020, is at an Overweight. PPD Inc. (PPD) has earlier revealed that it has received the honor of employer of choice around the world. PPD was recognized as a top 50 desirable employer in Bulgaria, according to the second annual Employer of Choice Survey organized by the employer brand and business consulting agency To The Top. This company market capitalization has remained high, hitting $11.61 billion at the time of writing.

    Adamis Pharmaceuticals Corporation (NASDAQ: ADMP)

    Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) last closed at $0.80, in a 52-week range of $0.27 to $1.51. Analysts have a consensus price target of $1.25. Adamis Pharmaceuticals Corporation (ADMP) has earlier revealed the pricing of its previously announced underwritten public offering of 16,129,032 shares of its common stock at a public offering price of $0.62 per share, resulting in gross proceeds of approximately $10,000,000.

    Rockwell Medical Inc. (NASDAQ: RMTI)

    Rockwell Medical Inc. (NASDAQ: RMTI) last closed at $1.76, in a 52-week range of $1.10 to $3.85. Rockwell Medical Inc. (RMTI) has earlier named Russell L. Skibsted, M.B.A., as Executive Vice President, Chief Financial Officer  and Chief Business Officer (CBO), effective from September 15, 2020. This company market capitalization has remained high, hitting $96.44 million at the time of writing.

    TherapeuticsMD Inc. (NASDAQ: TXMD)

    TherapeuticsMD Inc. (NASDAQ: TXMD) stock soars 2.75% to $1.44. The most recent rating by Jefferies, on August 07, 2020, is at an Underperform. TherapeuticsMD Inc. (TXMD) Knight Therapeutics Inc. and TherapeuticsMD, Inc. revealed that they received the approval of BIJUVA® (estradiol and progesterone) capsules by Health Canada. This company has a market capitalization of $368.06 million at the time of writing.

    Zoetis Inc. (NYSE: ZTS)

    Zoetis Inc. (NYSE: ZTS) rose 0.06% after gaining more than $0.01 on Tuesday. Zoetis Inc. (ZTS) has been recognized by Working Mother magazine for its career advancement opportunities, female representation and work-life programs. in the past 52-weeks of trading, Zoetis stock has fluctuated between the low of $90.14 and a high of $165.82. ZTS has moved up 78.59% from its 52-weeks low and moved down -2.92% from its 52-weeks high.  ZTS market cap has remained high, hitting $76.29 billion at the time of writing.

    DURECT Corporation (NASDAQ: DRRX)

    DURECT Corporation (NASDAQ: DRRX) stock drop by -5.41% to $1.75. The most recent rating by Oppenheimer, on July 31, 2020, is at an Outperform. DURECT Corporation (DRRX) has revealed the study design for the Phase 2b AHFIRM clinical trial of DUR-928 in severe alcoholic hepatitis (AH) patients. DURECT Corporation market cap has remained high, hitting $333.92 million at the time of writing.

    Elanco Animal Health Incorporated (NYSE: ELAN)

    Elanco Animal Health Incorporated (NYSE: ELAN) shares headed rising, higher as much as 0.56%. The most recent rating by Morgan Stanley, on August 20, 2020, is at an Overweight. In the past 52-weeks of trading, this company stock has fluctuated between the low of $15.17 and a high of 32.66. Elanco Animal Health Incorporated (ELAN) has moved up 76.01% from its 52-weeks low and moved down -18.25% from its 52-weeks high.

    Guardion Health Sciences Inc. (NASDAQ: GHSI)

    Guardion Health Sciences Inc. (NASDAQ: GHSI) rose 1.22% on Monday. Guardion Health Sciences Inc. (GHSI) share price went from a low point around $0.17 to briefly over $0.95 in the past 52 weeks, though shares have since pulled back to $0.25. Guardion Health Sciences Inc.’s market cap has remained high, hitting $22.26 million at the time of writing.

    Agile Therapeutics Inc. (NASDAQ: AGRX)

    Agile Therapeutics Inc. (NASDAQ: AGRX) shares headed falling, lower as much as -6.89%. The most recent rating by Janney, on April 12, 2019, is at a Buy. In the past 52-weeks of trading, Agile Therapeutics Inc. stock has fluctuated between the low of $0.35 and a high of $4.77. Agile Therapeutics Inc. has moved up 807.14% from its 52-weeks low and moved down -33.37% from its 52-weeks high.

    Momenta Pharmaceuticals Inc. (NASDAQ: MNTA)

    Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) stock drops 0.02% after losing -0.01 on Tuesday. Momenta Pharmaceuticals Inc. (MNTA) share price went from a low point around $12.21 to briefly over $52.45 in the past 52 weeks, though shares have since pulled back to $52.36. Momenta Pharmaceuticals Inc.’s market cap has remained high, hitting $6.24 billion at the time of writing.

    Catalent Inc. (NYSE: CTLT)

    Catalent Inc. (NYSE: CTLT) stock drop 0.86% to $84.81. The most recent rating by Argus, on June 25, 2020, is at a Buy. In the past 52-weeks of trading, Catalent Inc. (CTLT) stock has fluctuated between the low of $31.04 and a high of $95.70. Catalent Inc. has moved up 173.23% from its 52-weeks low and moved down -11.38% from its 52-weeks high.  Catalent Inc. market cap has remained high, hitting $13.94 billion at the time of writing.

    Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD)

    Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD) shares headed falling, lower as much as 2.22%. The most recent rating by Northland Capital, on June 17, 2020, is at an Outperform. Ironwood Pharmaceuticals Inc. (IRWD) share price went from a low point around $7.91 to briefly over $14.10 in the past 52 weeks, though shares have since pulled back to $9.48. Ironwood Pharmaceuticals Inc.’s market cap has remained high, hitting $1.54 billion at the time of writing.

    Athenex Inc. (NASDAQ: ATNX)

    Athenex Inc. (NASDAQ: ATNX) last closed at $12.80, in a 52-week range of $5.63 to $18.35. Athenex Inc. (ATNX) has moved up 127.35% from its 52-weeks low and moved down -30.25% from its 52-weeks high.  Athenex Inc. market cap has remained high, hitting $1.14 billion at the time of writing.